Literature DB >> 9892217

Leptin enhances glycogen storage in hepatocytes by inhibition of phosphorylase and exerts an additive effect with insulin.

S Aiston1, L Agius.   

Abstract

The effects of the adipocyte-derived hormone leptin on glucose metabolism in hepatocytes were investigated. Incubation of hepatocytes from Wistar rats with leptin for 16 h caused a dose-dependent increase in incorporation of [14C]glucose into glycogen, with a maximal effect at 30 nmol/l leptin. This effect of leptin was observed over a range of glucose concentrations (10-25 mmol/l) and was associated with stimulation of net glycogen deposition. It was not counteracted by mercaptopicolinate, an inhibitor of phosphoenolpyruvate carboxykinase, indicating that it is not due to increased gluconeogenic flux. Leptin also enhanced the short-term stimulation of glycogen synthesis by insulin. These effects of leptin were associated with inhibition of phosphorylase a, which occurred after 4 h of exposure to leptin. Culture with leptin for 16 h did not affect the activities of glucose-6-phosphatase or glucokinase or the activation state of glycogen synthase. Leptin did not affect glycolysis determined from the detritiation of [3-(3)H]glucose. The inhibitory effects of leptin on phosphorylase a were counteracted by short-term incubation with glucagon but were additive with the inhibitory effects of insulin and also with the inhibition caused by resorcinol (25 pmol/l), which inhibits phosphorylase kinase by a mechanism analogous to the antidiabetic drug proglycosyn. These results show that leptin has additive effects with insulin in inhibiting phosphorylase and stimulating glycogen storage in hepatocytes, indicating that these hormones act by separate but convergent mechanisms. It is concluded that the primary action of leptin in hepatocytes is to enhance glycogen storage. This may be an important compensatory mechanism for the inhibition of insulin secretion.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9892217     DOI: 10.2337/diabetes.48.1.15

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  14 in total

1.  The role of protein kinase B/Akt in insulin-induced inactivation of phosphorylase in rat hepatocytes.

Authors:  S Aiston; L J Hampson; C Arden; P B Iynedjian; L Agius
Journal:  Diabetologia       Date:  2005-12-10       Impact factor: 10.122

2.  PER2 promotes glucose storage to liver glycogen during feeding and acute fasting by inducing Gys2 PTG and G L expression.

Authors:  Fabio Zani; Ludovic Breasson; Barbara Becattini; Ana Vukolic; Jean-Pierre Montani; Urs Albrecht; Alessandro Provenzani; Juergen A Ripperger; Giovanni Solinas
Journal:  Mol Metab       Date:  2013-07-01       Impact factor: 7.422

3.  Copy number variation at leptin receptor gene locus associated with metabolic traits and the risk of type 2 diabetes mellitus.

Authors:  Jae-Pil Jeon; Sung-Mi Shim; Hye-Young Nam; Gil-Mi Ryu; Eun-Jung Hong; Hyung-Lae Kim; Bok-Ghee Han
Journal:  BMC Genomics       Date:  2010-07-12       Impact factor: 3.969

4.  Glucose 6-phosphate causes translocation of phosphorylase in hepatocytes and inactivates the enzyme synergistically with glucose.

Authors:  Susan Aiston; Andrew Green; Mohammed Mukhtar; Loranne Agius
Journal:  Biochem J       Date:  2004-01-01       Impact factor: 3.857

5.  Diverse effects of two allosteric inhibitors on the phosphorylation state of glycogen phosphorylase in hepatocytes.

Authors:  Theodore Latsis; Birgitte Andersen; Loranne Agius
Journal:  Biochem J       Date:  2002-11-15       Impact factor: 3.857

6.  An assessment of the in vivo efficacy of the glycogen phosphorylase inhibitor GPi688 in rat models of hyperglycaemia.

Authors:  S M Poucher; S Freeman; S J G Loxham; G Convey; J B Bartlett; J De Schoolmeester; J Teague; M Walker; A V Turnbull; A D Charles; F Carey; S Berg
Journal:  Br J Pharmacol       Date:  2007-10-15       Impact factor: 8.739

7.  Polymorphisms in the leptin receptor (LEPR)--putative association with obesity and T2DM.

Authors:  Kyong Soo Park; Hyoung Doo Shin; Byung Lae Park; Hyun Sub Cheong; Young Min Cho; Hong Kyu Lee; Jong-Young Lee; Jong-Keuk Lee; Bermseok Oh; Kuchan Kimm
Journal:  J Hum Genet       Date:  2005-12-07       Impact factor: 3.172

8.  Astroglial CB1 cannabinoid receptors regulate leptin signaling in mouse brain astrocytes.

Authors:  Barbara Bosier; Luigi Bellocchio; Mathilde Metna-Laurent; Edgar Soria-Gomez; Isabelle Matias; Etienne Hebert-Chatelain; Astrid Cannich; Marlène Maitre; Thierry Leste-Lasserre; Pierre Cardinal; Juan Mendizabal-Zubiaga; Miren Josune Canduela; Leire Reguero; Emmanuel Hermans; Pedro Grandes; Daniela Cota; Giovanni Marsicano
Journal:  Mol Metab       Date:  2013-08-09       Impact factor: 7.422

9.  Inhibitory effects of leptin on pancreatic alpha-cell function.

Authors:  Eva Tudurí; Laura Marroquí; Sergi Soriano; Ana B Ropero; Thiago M Batista; Sandra Piquer; Miguel A López-Boado; Everardo M Carneiro; Ramón Gomis; Angel Nadal; Ivan Quesada
Journal:  Diabetes       Date:  2009-04-28       Impact factor: 9.461

10.  Selective interaction between leptin and insulin signaling pathways in a hepatic cell line.

Authors:  I Szanto; C R Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.